ライフサイエンスコーパス: postinjection

1 o 8 h after injection (10-fold elevation 4 h postinjection).

2 (111)In-IMP288 (9.1 +/- 2.8% ID/g at 2 hours postinjection).

3 l replication in salmon brains up to 15 days postinjection.

4 ained at baseline and at 2 weeks and 6 weeks postinjection.

5 aphy was done on other animals until 5 weeks postinjection.

6 with c(RGDyK) ( approximately 4%ID/g) 1 hour postinjection.

7 m of all S129A-treated rats as early as 4 wk postinjection.

8 % injected dose per gram of tissue at 30 min postinjection.

9 P to flu (PSMA-PC3) ratio of 44:1 at 120 min postinjection.

10 5 h) reached a maximum of 28.0% ID/g at 12 h postinjection.

11 tter than that of 99mTc-Sestamibi at 120 min postinjection.

12 stration of purified Stx2 and peaked at 48 h postinjection.

13 ing mice administered with 64Cu-L1 as 30 min postinjection.

14 measurement of food intake at 1, 2, and 4 h postinjection.

15 erved effects were relatively small at 0.5 h postinjection.

16 Mice were killed 3, 8, or 22 days postinjection.

17 d peak uptake being achieved in about 55 min postinjection.

18 quent food intake was measured 1, 2, and 4 h postinjection.

19 and best tumor/background contrast after 4 h postinjection.

20 respectively, of that accumulated at 8 hours postinjection.

21 W/cm2 for 2.5 h (lambda(max) 665 nm) at 24 h postinjection.

22 formed from 3 hours preinjection to 24 hours postinjection.

23 normal allele (RLC-47N) assayed at 16 weeks postinjection.

24 .2% ID/g) and the kidneys (4.8% ID/g) at 4 h postinjection.

25 rocessed for Fos immunohistochemistry at 1 h postinjection.

26 levels of AMMN-derived O(6)-mG at 4 and 96 h postinjection.

27 kedly from 40% at 1 month to <5% by 3 months postinjection.

28 fold increase in liver MnSOD activity 7 days postinjection.

29 le and food intake was measured 1, 2 and 4 h postinjection.

30 not increase food intake over the first 4 h postinjection.

31 leading to sustained survival over 120 days postinjection.

32 ice failed to develop scrapie up to 503 days postinjection.

33 5-Se/g of tumor was found at 3, 6, and 24 h postinjection.

34 n the first 24 hours, which abated by 7 days postinjection.

35 detected by immunohistochemistry up to 2 wk postinjection.

36 pectively, 30% and 10% of that recovered 1 h postinjection.

37 ed with the parental chTNT-3 6, 12, and 24 h postinjection.

38 in the MPO by 55 +/- 6% (P < 0.0001) at 1 h postinjection.

39 n, starting on days 1-3 and peaking on day 7 postinjection.

40 ocyte-specific PDE5 overexpression at 30 min postinjection.

41 mes higher than the other derivatives at 4 h postinjection.

42 ed in the eyes of control animals at 6 weeks postinjection.

43 rmTPO) intravenously and were killed 3 hours postinjection.

44 creatic tumor tissue in vivo as early as 1 h postinjection.

45 biopsy was performed 1.5-6 hr (mean = 3 hr) postinjection.

46 um-to-occipital ratio (SOR) of 3.5 at 90 min postinjection.

47 were then killed at 6, 24, 48, 96 and 168 hr postinjection.

48 (SPECT) images were obtained 14 to 20 hours postinjection.

49 amount of radioactivity (1.54% ID/g) at 24 h postinjection.

50 -[125I]IPBS was observed (7.40% ID/g) at 1 h postinjection.

51 [(18)F]5, and [(18)F]6, respectively, at 2 h postinjection.

52 tion of NPY and food intake was measured 1 h postinjection.

53 etect mRNAs for several cytokines at 3 hours postinjection.

54 ining in 0.25% of hepatocytes 8 to 10 months postinjection.

55 the donor-type human cells recovered 9 weeks postinjection.

56 density of gephyrin clusters 19 and 35 days postinjection.

57 +/- 1.6% ID/g and 5.2% +/- 4.4% ID) at 4 hr postinjection.

58 s 2-5 min, 10-15 min, 30-45 min and 1-1.5 hr postinjection.

59 intervals (1-2, 1-2.5, 1.5-2.5 and 2-3 min) postinjection.

60 d significant contrast enhancement up to 4 h postinjection.

61 onstruct was only 5-10% of wild-type at 8 mo postinjection.

62 ated radioactivity was determined at 2 hours postinjection.

63 on Days 3 and 7 and between 4-6 and 8-10 wk postinjection.

64 3.0% ID/g with [125I]-Tyr4-bombesin at 4 hr postinjection.

65 o-blood (0.20% ID/g) ratio was 1:2 at 30 min postinjection.

66 cytometry at either 6 to 8 weeks or 6 months postinjection.

67 r tamoxifen and euthanized at 12 or 24 weeks postinjection.

68 er with pulse-like kinetics that peak at 3 h postinjection.

69 is limited owing to a changing concentration postinjection.

70 6% ID/g) among these (99m)Tc-peptides at 2 h postinjection.

71 ancement in signal in tumor-bearing mice 2 h postinjection.

72 ptomatic lesions were detected up to 5 years postinjection.

73 ssue showed moderate ALP activity at 13 days postinjection.

74 ation were performed at 24, 48, 72, and 96 h postinjection.

75 formed preinjection, and at 1, 2, and 4 days postinjection.

76 time course of events ranging from 1 to 21 d postinjection.

77 2 weeks postinjection, and 35.4% at 3 weeks postinjection.

78 ht be important for both steroids at 1 month postinjection.

79 l resolution of organs as a function of time postinjection.

80 , n=3, showed faster brain washout at 30 min postinjection (0.42 and 1.57% dose/g) as compared to the

81 served for the initial brain uptake at 2 min postinjection (0.50% and 0.28% dose/organ for 2A,B, resp

82 At 30 min postinjection, [11C]MTICU remained 64% intact in vivo an

83 Postinjection 180-day event rates per 100 patients for M

84 The 2-h postinjection [18F]FEAU uptake levels were 3.3% +/- 1.0%

85 At 6, 12, and 24 h postinjection 1alpha,24(R), 25-trihydroxy-[26,27-(3)H]vi

86 d PTX-RGD showed highest tumor uptake at 2 h postinjection (2.72 +/-0.16%ID/g) and best tumor/backgro

87 in vesicles beneath the cuticular plate 27 h postinjection; (2) the number of vesicles per hair cell

88 the standard 4-week interval: 6.3% at 1 week postinjection, 22.9% at 2 weeks postinjection, and 35.4%

89 Controls were imaged at 24 hr postinjection 222 MBq (6 mCi) [123I]-beta-CIT and serial

90 Ci) [123I]-beta-CIT and serially from 1-6 hr postinjection 333 MBq (9 mCi) [123I]-FPCIT.

91 At 6 months postinjection, 67% of control subjects experienced a maj

92 t of activity from the tumor was slow at 6 h postinjection (7.22% ID/g).

93 e -81.5 +/- 4.5% versus -19.6 +/- 5.2% (24 h postinjection, 7.0 T), respectively.

94 rong and specific uptake in AR42J tumors 4 h postinjection (9.3+/-1.6% ID/g vs 0.3+/-0.0% ID/g during

95 Axonal Guidance Signaling System." At 1 week postinjection a common theme was activation of genes exp

96 ctions, plastic surgery wound infections, or postinjection abscesses.

97 r injection, and time between injections and postinjection acquisitions were identical for both exami

98 were monitored rectally every 30 min for 3 h postinjection, after which, the animals were sacrificed.

99 At 8 h postinjection, Agrp increased feeding in the PVN by 218

100 Eight weeks postinjection, all hearts were instrumented with a pulmo

101 At 2-h postinjection, alpha(nu)beta(3)-targeted paramagnetic na

102 Two weeks postinjection, alpha-gal A activity in the livers of rAA

103 U1 RNA, at 24 hours' postinjection, also increased expression of the early ac

104 ts, with tumor-to-kidney ratios of >1 by 4 h postinjection, an important benchmark.

105 d given a first bladder void break at 40 min postinjection and a second void at the end of study at 1

106 Blood samples were collected until 3 h postinjection and counted in a gamma counter.

107 tudies extended these analyses for 40 months postinjection and evaluated whether the longevity of tra

108 bstantially lower levels of HBV DNA at day 4 postinjection and higher levels of ISG mRNAs.

109 osquitoes were significantly smaller by 48 h postinjection and lacked eggshell proteins.

110 s detected in retinal vascular cells at 24 h postinjection and persisted until day 6 (the end point o

111 ted dose per gram (ID/g) was seen at 4 hours postinjection and remained at 5.91% ID/g at 24 hours, wi

112 produced high-contrast immuno-PET images 4 h postinjection and showed specific uptake in the spleen a

113 GH levels (15.0 +/- 2.4 ng/mL) at 40 minutes postinjection and tended to decrease fasting gastric vol

114 ols rose approximately 1 degrees C by 80 min postinjection and then gradually abated over the followi

115 peak tracer uptake in the brain within hours postinjection and to provide greater selectivity for the

116 ined from rabbit knee joints on days 3 and 7 postinjection and used for analysis of IGF-1 expression,

117 induction in brain that peaked at 2-3 hours postinjection and whose strength was dose-related.

118 igh tumor uptake (31.4 +/- 10.8%ID/g at 36 h postinjection) and a tumor/muscle ratio of 76.4 +/- 52.3

119 (90% injected dose per gram of tissue at 2 h postinjection) and high tumor-to-organ ratios, [(18)F]23

120 3% at 1 week postinjection, 22.9% at 2 weeks postinjection, and 35.4% at 3 weeks postinjection.

121 hrough the lungs and kidneys several seconds postinjection, and spleen and liver at slightly later ti

122 thin 16 hours ( approximately 50% depletion) postinjection, and the alpha-SMA+ stroma population was

123 ials onto abducens motoneurons within 2 days postinjection, and transmission remains blocked for at l

124 Imaging was repeated 1 and 2 weeks postinjection, and visually evoked potentials (VEPs) and

125 Nine days postinjection, animals were euthanized and stomachs and

126 0.04% among injections with preinjection and postinjection antibiotics (P = 0.20).

127 ntibiotics only, 0.06% among injections with postinjection antibiotics only, and 0.04% among injectio

128 Use of preinjection and postinjection antibiotics was at the discretion of the t

129 endophthalmitis compared with those without postinjection antibiotics.

130 light exposure of 135 J/cm2 (75 mW/cm2; 24 h postinjection) at 796 nm for 30 min produced a 60% long-

131 led least-squares modeling of local pre- and postinjection baselines.

132 ose (0.1 nmol) during 30 minutes to 24 hours postinjection, because of partial self-inhibition of rec

133 ciception more rapidly (maximal effect at 1h postinjection) but also lose their analgesic activity fa

134 unoreactive clusters were observed at 5 days postinjection, but we found significant reductions (25-4

135 Postinjection changes in muscle fiber morphometry and ul

136 Pre- and postinjection CNR measurements at identical spatial posi

137 lization of the microsphere deposition, with postinjection CNR values (mean, 14.29 +/- 3.98 [standard

138 t all time points (30, 60, 120, 180, 240 min postinjection), colocalized Fos and Jun immunostaining w

139 ng PC3 tumors (12.4 +/- 3.7% ID/g at 2 hours postinjection), comparable with (111)In-IMP288 (9.1 +/-

140 os are higher with In-IgM at all time points postinjection compared to that of In-IgG.

141 At 60 min postinjection, compound I gave the highest prostate to s

142 uscle injection site and draining lymph node postinjection, consistent with the rapid drainage of the

143 The camera resolution at postinjection counting rates was 11.7% full width at hal

144 Rds mRNA levels peaked at postinjection day 2 to 7 (PI-2 to PI-7) for P5 injection

145 tinjection day 7, diminishing to baseline by postinjection day 28.

146 levels were found in the vitreous peaking at postinjection day 7, diminishing to baseline by postinje

147 nfluence feeding behavior for the first 3 hr postinjection, decreased food intake dose dependently by

148 Maximum accumulation occurred at 6 hours postinjection, demonstrating specific intratumoral probe

149 injection and evaluated at 1 day and 1 week postinjection did not show a decrease in either hypoxia

150 By 14 days postinjection (dpi), 8 of 10 WT mice died, compared with

151 At 6 d postinjection (dpi), axons were stripped of myelin, and

152 The effects of postinjection elevation of intraocular pressure (IOP), i

153 orhexidine was associated with a low rate of postinjection endophthalmitis and was well tolerated by

154 The combined rate of postinjection endophthalmitis at these 2 centers was 0.0

155 face mask use did not influence the risk of postinjection endophthalmitis compared to a no-talking p

156 s caused outbreaks of sterile and infectious postinjection endophthalmitis in at least 3 countries du

157 Among 42 patients with postinjection endophthalmitis, 5 (11.9%) did not receive

158 be an independent risk factor for recurrent postinjection endophthalmitis.

159 of the injected dose (%ID) in tumor at 4 hr postinjection (equating to 5.2 +/- 1.5 %ID/g tumor; n =

160 of striatal uptake enabling imaging 14-24 hr postinjection for stable quantitative measures of dopami

161 ograft uptake time of 5 h compared with 48 h postinjection for the intact antibody.

162 Tumor uptake at 1 hour postinjection for two high-affinity (IC(50), approximate

163 At 45 min postinjection, hard lemon candy was given for 15 min as

164 At later times (> 52 h postinjection), high vector doses (multiplicity of infec

165 mplex class II (monoclonal antibody OX-6) on postinjection hours 0, 2, 4 and 8 and days 1, 3, 7, 14 a

166 and compared image interpretation between 2 postinjection imaging times.

167 In vivo MRI revealed that at 24 h postinjection, immunomicelles provided a 79% increase in

168 cted in tumor-bearing animals up to 6 months postinjection in association with the murine T-cell tumo

169 turnal Mobitz I AV conduction occurred early postinjection in both groups.

170 [18F]fluoromisonidazole (FMISO) at 2 and 4 h postinjection in C3H mice bearing KHTn tumors (130-430 m

171 ne, were investigated at 0.5, 1, and 3 hours postinjection in rats.

172 lesion could be delineated as early as 8 hr postinjection in the 99MTc window, the best target-to-no

173 of the embryo at the time of injection, and postinjection incubation temperature.

174 injection stops, hindering the occurrence of postinjection induced seismicity.

175 A total of 20 cases of postinjection inflammation were identified in 5356 aflib

176 to 2 mm of the mucocutaneous junction at all postinjection intervals.

177 At the peak of virus replication, at 4 days postinjection, intrahepatic markers of HBV replication w

178 Postinjection IOP elevation, injection frequency, and to

179 se of acute virus replication, and at 4 days postinjection, it was reduced by nearly 2 logs in the ab

180 Comparison of pre- and postinjection means showed that treatment with the contr

181 al irritation leading to death 30 to 63 days postinjection (median, 36.0 days, mean, 38.7); death occ

182 ssfully modified by our laboratory whereby a postinjection methylation reaction, rather than silylati

183 f injection showed the best response, with a postinjection MIO similar to that in age-matched control

184 XFM-guided injections were compared with postinjection MRI and with necropsy specimens obtained 2

185 By 12 days postinjection, MSCs migrated throughout the forebrain an

186 tumor/muscle ratio of 120.2 +/- 44.4 at 36 h postinjection; n = 4) compared with each monospecific Fa

187 At early time points (15 and 30 minutes postinjection), nuclear and possibly cytoplasmic fluores

188 ly visualized by SPECT/CT as early as 1 hour postinjection of ((9)(9)m)Tc-M40.

189 iltered tungsten lamp at 200 mW cm(-2) (24 h postinjection of 5-Se).

190 stabilities and biodistributions out to 1 h postinjection of 67/68Ga and 111In chelates of 4SS, 5SS,

191 njection of 111 MBq (3mCi) 201Tl and at 1 hr postinjection of 925 MBq (25 mCi) 99mTc-sestamibi.

192 During the time period 40-80 min postinjection of [(18)F]9, the ratio of uptake in the pu

193 uggest that SPECT imaging performed at 24 hr postinjection of [123I]beta-CIT permits calculation of r

194 At 2 hr postinjection of IBZM, the mean BG/CE ratio in normals w

195 n liver and muscle tissues was compared with postinjection of INS or ProINS-Tf.

196 dder activity was identified or up to 90 min postinjection of mebrofenin.

197 Cryo(DeltaLRR Z/DeltaLRR Z) mice at 6 hours postinjection of MSU crystals compared with WT mice.

198 induced in the periarticular tissue of mice postinjection of MSU crystals.

199 onvisualization of the gallbladder at 90 min postinjection of radiotracer.

200 le-body gamma camera images were taken 4-5 h postinjection of the radiolabeled biotin.

201 At 7 wk postinjection of the radiolabeled MAbs, tumor volume in

202 intratumoral retention (~85% ID/tumor 7 days postinjection) of the radionuclide, elicited a tumor gro

203 tem, locomotor behavior was recorded for 2-h postinjection on both days.

204 Three days postinjection, on E14, a total of 259 AP-labeled clones

205 ol animals delivered at term 60 +/- 15 hours postinjection (p.i.), those administered with O111:B4 de

206 striatum/cerebellum ratio of 1.88 at 30 min postinjection (p.i.).

207 .2 and 26.5 nmol) into the NAc at 2- and 4-h postinjections (P<0.05).

208 d 26.5 nmol) into the CeA at 1-, 2-, and 4-h postinjections (P<0.05).

209 pain level, the mean differences in pre- and postinjection pain and preinjection pain and post-MR ima

210 gions; this ratio increased from 5 to 30 min postinjection, particularly for [(18)F]18a-d and [(18)F]

211 PVN) in fasted as well as fed rats at 10-min postinjection, particularly in the medial parvocellular

212 plex, varied significantly during the 42-day postinjection period (P < .05, ANOVA).

213 atlak plot was linear over the 20- to 95-min postinjection period (r = 0.97 +/- 0.1).

214 ly decreased over the following 20 h (4-24 h postinjection period) in the orexin A 3 nmol injected gr

215 0-min windows that spanned the 30- to 90-min postinjection period.

216 e events related to the vector in the 3-year postinjection period.

217 n those of Rpe65(-/-) mice, after the longer postinjection periods.

218 Comparison of mean 5-minute preinjection and postinjection physiologic parameters in 27 patients who

219 n of mean 5-minute preinjection and 5-minute postinjection physiological data.

220 dynamically measured with IR-EPI during 1 h postinjection (PI).

221 d complexes showed fast blood clearance (2 h postinjection (pi): (111)In-S, 0.07 +/- 0.03% ID/g; (111

222 Imaging was performed from 4-240 hr postinjection (planar and SPECT).

223 different etiologies, including endogenous, postinjection, post-cataract surgery, and other anterior

224 After an incubation of 4 days postinjection, PRV-infected neurons were located immunoc

225 s, including baseline (before injection) and postinjection readings (5 min, 30 min, 4 h, 24 h, 48 h,

226 of NP-specific IgM and IgG (on days 8 and 16 postinjection, respectively).

227 cted dose per gram) and 3.3%id per g at 48 h postinjection, respectively.

228 delayed compared with ICP (28 vs. 4 minutes postinjection), resulting in a dramatic translaminar pre

229 Autoradiography of aortae at 2 h postinjection revealed high uptake of [(99m)Tc]-1 in AAA

230 of epidermal biopsies taken at 1 to 2 weeks postinjection revealed that these MMP3-expressing Sp-1 l

231 Postinjection RIF counts were significantly higher than

232 Considering the 24 hr postinjection scans only, there was a nonsignificant tre

233 nic MnCl(2), comparisons of preinjection and postinjection scans, and voxelwise statistical mapping.

234 parisons of at least 10 preinjection and two postinjection scans.

235 Eight weeks postinjection, significant increases in the pulmonary ar

236 in mixed with CD-cholesterol had, at 7 hours postinjection, significantly smaller erosions than eyes

237 y-eight whole-body PET studies acquired with postinjection singles transmission scans were analyzed.

238 ll wells for all measurements as part of the postinjection site care.

239 th adhesion resolution-necessitating careful postinjection spectral-domain optical coherence tomograp

240 1 muL automatic internal sample injector, a postinjection splitter with 1:10 splitting ratio, and a

241 red by high concentrations of effector cells postinjection, such as induced by higher bacterial loads

242 se to spontaneous Cl- currents within 6-12 h postinjection, suggesting that the early spontaneous act

243 ed in both LN and spleens at all time points postinjection, suggesting that the vector alone affected

244 then examined for anti-BrdU-labeled cells at postinjection survival times from 30 min to 10 d.

245 and the susceptibility artifacts seen on the postinjection T2*-weighted gradient echo MRI.

246 ors were exposed to light for 30 min at 24 h postinjection), the benzobacteriochlorins containing N-s

247 rance efficiency (60% injected doses at 24 h postinjection), the reporters can be used for optical ur

248 fically, in the preinjected group, at 15 min postinjection, the 125I-labeled anti-Tac dsFv levels in

249 By 7 days postinjection, the protein-bound cysteinyl catechols wer

250 hin the time interval between 95 and 115 min postinjection, the radioactivity retained in the kidneys

251 At 60 min postinjection, the tumor vs normal brain ratio of radioa

252 In the ADF group at 28 days postinjection, there were prolongations of PR interval (

253 al vein thrombin in the canine model by 1 hr postinjection (thrombus-to-blood ratio of 4.4 and thromb

254 ignificantly higher than control eyes at all postinjection times (PI; P <or= 0.004).

255 (3)H)retinol in all mice exhibited a peak at postinjection times of 1.5 or 4.5 hours, and by 48 hours

256 Thirty patients received 2 PEM scans at postinjection times of 60 and 120 min.

257 At longer postinjection times, retinal ganglion cells in the contr

258 onic ages were killed at different intervals postinjection to follow postmitotic cells' positional ch

259 Tumors were excised between 5 and 55 min postinjection to quantify tracer uptake while arterial p

260 ls of liver and abdominal radioactivity 24 h postinjection to tumor-bearing rats.

261 both acute RVP and sustained focal RVP (24 h postinjection) to a greater extent in diabetic rats comp

262 Using postinjection topical antibiotic drops does not reduce t

263 g povidone-iodine 5% alone in the absence of postinjection topical antibiotics does not appear to pro

264 iodine 5% without the use of preinjection or postinjection topical antibiotics.

265 3 prior intravitreal injections with use of postinjection topical antibiotics.

266 Postinjection transmission data were used to correct pat

267 era coincidence scanner that can be used for postinjection transmission scanning has been developed.

268 In the minority of postinjection trials when the animals responded correctl

269 24, 48, 96, and 168 h for (177)Lu-NeoBOMB1) postinjection tumor and organ uptake was determined.

270 With (64)Cu-TP3982, the 4-h postinjection tumor uptake was 10.8 +/- 2.1 %ID/g versus

271 Six hours postinjection, VEGF/VPF-treated rats exhibited a threefo

272 dverse drug reactions (ADRs) reported during postinjection visits and investigator telephone calls we

273 T scans were obtained at baseline and at all postinjection visits, and for patients with baseline FTM

274 Secondary endpoints included postinjection visual acuity and rates of outer retinal a

275 The In-IgM activity in blood at 4 hr postinjection was 27% which decreased to 2% by 36 hr.

276 to-normal brain uptake ratio at 55 to 95 min postinjection was 47.5 for [11C]TPMP and 8.1 for [68Ga]E

277 by the popliteal and axillary nodes at 6-hr postinjection was approximately 0.5%.

278 The tumor uptake at 5 days postinjection was found to be 12.5 +/- 0.7% which was in

279 Radioactivity due to 18F-FPH at 130 min postinjection was highest in the thalamus and hypothalam

280 Serum S-SMase activity 3 h postinjection was increased 2- to 2.5-fold by LPS (P < 0

281 We showed that FKRP expression at 10 months postinjection was reduced by about 50% with a single shR

282 Tracer uptake at 60 min postinjection was reduced in a blocking study using a kn

283 of ghrelin (2.83 +/- 0.13 pmol/ml at 60 min postinjection) was not significantly different from that

284 umor/blood and tumor/muscle ratios at 90 min postinjection were 6 and 33 for 99mTc-P587, 21 and 68 fo

285 , suggesting that the early events occurring postinjection were required for these elevated adaptive

286 etention of [11C]HED taken from 50 to 60 min postinjection were used to differentiate sympathetically

287 tected in cerebrospinal fluid (CSF) on day 4 postinjection, were variably present over the ensuing 17

288 versus 17.7 +/- 7.0% injected dose at 24 hr postinjection), whereas the uptake of all other organs r

289 e observed in the eyes for at least 24 weeks postinjection, whereas no photoreceptor cells remained i

290 c-D-Lys((125)I-IBA)-ReCCMSH(Arg(11)) at 24 h postinjection, whereas values of 4.3 and 2.0 were observ

291 D/g) within PSMA(+) PC-3 PIP tumor at 30 min postinjection, which persisted, with clear delineation o

292 (33)P-TFO accumulated in the liver at 30 min postinjection, which was significantly higher than that

293 sue (%ID/g) within PSMA+ PIP tumor at 30 min postinjection, while [(68)Ga]6 showed a 2 h PSMA+ PIP tu

294 gand 18a, this same ratio was 8.4 at 120 min postinjection, while compound 18c displayed a lower spec

295 Mice were transplanted 7 days postinjection with donor (bm1 or F1) and third-party B10

296 ted very encouraging results as early as 1 h postinjection with high tumor uptake (14.33% +/- 2.11% I

297 wed 3% ID/g in LNCaP xenograft tumors at 1 h postinjection with tumor-to-blood and tumor-to-muscle ra

298 A-derived activity was in metabolites at 2 h postinjection, with 15% in metabolites by 4 h; comparabl

299 ed cells were observed for at least 6 months postinjection without evidence of cell loss or neural da

300 nograft/blood ratios, reaching 19:1 at 120 h postinjection Xenograft regression using single doses of